Cite
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
MLA
Ayala, Rosa, et al. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5556ce37b52bc293ff64fa02d5985a20&authtype=sso&custid=ns315887.
APA
Ayala, R., Rapado, I., Onecha, E., Martínez-Cuadrón, D., Carreño-Tarragona, G., Bergua Burgues, J. M., Vives Polo, S., Algarra, J. L., Tormo, M., Martinez, P., Serrano, J., Herrera, P., Ramos, F., Salamero, O., Lavilla, E., Gil, C., López Lorenzo, J. L., Vidriales, M. B., Labrador, J., … Universitat Autònoma de Barcelona. (2021). The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
Chicago
Ayala, Rosa, Inmaculada Rapado, Esther Onecha, David Martínez-Cuadrón, Gonzalo Carreño-Tarragona, Juan Miguel Bergua Burgues, Susana Vives Polo, et al. 2021. “The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5556ce37b52bc293ff64fa02d5985a20&authtype=sso&custid=ns315887.